hydrochlorothiazide

Generic: hydrochlorothiazide

Labeler: sciegen pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name hydrochlorothiazide
Generic Name hydrochlorothiazide
Labeler sciegen pharmaceuticals, inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

hydrochlorothiazide 50 mg/1

Manufacturer
ScieGen Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 50228-112
Product ID 50228-112_5c6f4c6a-cc43-4f4d-bc16-688310c98c72
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA203018
Listing Expiration 2026-12-31
Marketing Start 2014-02-05

Pharmacologic Class

Established (EPC)
thiazide diuretic [epc]
Chemical Structure
thiazides [cs]
Physiologic Effect
increased diuresis [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 50228112
Hyphenated Format 50228-112

Supplemental Identifiers

RxCUI
197770 310798
UPC
0350228111300 0350228111102 0350228112109
UNII
0J48LPH2TH
NUI
N0000175359 N0000175419 M0471776

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name hydrochlorothiazide (source: ndc)
Generic Name hydrochlorothiazide (source: ndc)
Application Number ANDA203018 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 50 mg/1
source: ndc
Packaging
  • 1000 TABLET in 1 BOTTLE (50228-112-10)
  • 30 TABLET in 1 BOTTLE (50228-112-30)
source: ndc

Packages (2)

Ingredients (1)

hydrochlorothiazide (50 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "5c6f4c6a-cc43-4f4d-bc16-688310c98c72", "openfda": {"nui": ["N0000175359", "N0000175419", "M0471776"], "upc": ["0350228111300", "0350228111102", "0350228112109"], "unii": ["0J48LPH2TH"], "rxcui": ["197770", "310798"], "spl_set_id": ["02e96a51-1d56-460c-8c20-3d6f37e0ce46"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]"], "manufacturer_name": ["ScieGen Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1000 TABLET in 1 BOTTLE (50228-112-10)", "package_ndc": "50228-112-10", "marketing_start_date": "20140205"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (50228-112-30)", "package_ndc": "50228-112-30", "marketing_start_date": "20140205"}], "brand_name": "Hydrochlorothiazide", "product_id": "50228-112_5c6f4c6a-cc43-4f4d-bc16-688310c98c72", "dosage_form": "TABLET", "pharm_class": ["Increased Diuresis [PE]", "Thiazide Diuretic [EPC]", "Thiazides [CS]"], "product_ndc": "50228-112", "generic_name": "Hydrochlorothiazide", "labeler_name": "ScieGen Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Hydrochlorothiazide", "active_ingredients": [{"name": "HYDROCHLOROTHIAZIDE", "strength": "50 mg/1"}], "application_number": "ANDA203018", "marketing_category": "ANDA", "marketing_start_date": "20140205", "listing_expiration_date": "20261231"}